eHealth, Inc. (NASDAQ:EHTH - Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.77 and traded as high as $10.24. eHealth shares last traded at $9.94, with a volume of 290,787 shares trading hands.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on EHTH. Craig Hallum raised shares of eHealth from a "hold" rating to a "buy" rating and increased their target price for the company from $5.00 to $7.00 in a research report on Wednesday, November 6th. UBS Group started coverage on eHealth in a report on Wednesday, December 4th. They set a "neutral" rating and a $5.50 price objective for the company. Royal Bank of Canada lowered their target price on eHealth from $13.00 to $11.00 and set a "sector perform" rating on the stock in a research note on Monday, November 25th. Finally, StockNews.com raised eHealth from a "sell" rating to a "hold" rating in a research report on Tuesday, November 5th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $6.38.
View Our Latest Research Report on eHealth
eHealth Price Performance
The firm has a market cap of $298.08 million, a P/E ratio of -3.53 and a beta of 0.32. The business's fifty day simple moving average is $8.33 and its 200-day simple moving average is $5.86. The company has a current ratio of 3.10, a quick ratio of 3.10 and a debt-to-equity ratio of 0.14.
Institutional Trading of eHealth
A number of institutional investors have recently added to or reduced their stakes in EHTH. R Squared Ltd purchased a new position in eHealth during the 4th quarter valued at about $29,000. Public Employees Retirement System of Ohio grew its stake in eHealth by 40.7% during the third quarter. Public Employees Retirement System of Ohio now owns 12,451 shares of the financial services provider's stock valued at $51,000 after acquiring an additional 3,600 shares in the last quarter. Algert Global LLC increased its holdings in eHealth by 76.6% during the 2nd quarter. Algert Global LLC now owns 18,392 shares of the financial services provider's stock worth $83,000 after acquiring an additional 7,980 shares during the period. SkyView Investment Advisors LLC increased its holdings in eHealth by 28.7% during the 3rd quarter. SkyView Investment Advisors LLC now owns 30,000 shares of the financial services provider's stock worth $122,000 after acquiring an additional 6,694 shares during the period. Finally, Squarepoint Ops LLC purchased a new stake in eHealth in the 2nd quarter worth approximately $178,000. Hedge funds and other institutional investors own 79.54% of the company's stock.
About eHealth
(
Get Free Report)
eHealth, Inc operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services.
Read More
Before you consider eHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eHealth wasn't on the list.
While eHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.